JULIUS CLINICAL RESEARCH BV

Their core work

Julius Clinical Research is a Dutch contract research organization (CRO) specializing in the design, management, and execution of large-scale clinical trials across Europe. They bring methodological rigor to multi-center studies, handling trial coordination, data management, and statistical analysis for complex interventional and observational research. Their work spans chronic diseases, oncology supportive care, and — more recently — decentralized and remote clinical trial infrastructure, positioning them at the intersection of traditional clinical research and digital health innovation.

What they specialise in

How they've shifted over time

In their early H2020 involvement (2018), Julius Clinical focused on traditional large-scale clinical trials in chronic diseases — cystic fibrosis treatment personalization (HIT-CF) and renal replacement therapy comparison (CONVINCE). From 2019 onward, there is a clear pivot toward remote and digitally-enabled clinical research: Trials@Home established infrastructure for decentralized trials, COVID-RED deployed wearables for remote disease detection, and PREFERABLE explored patient-reported outcomes in oncology. The shift from conventional hospital-based trials to remote, technology-enabled research design is unmistakable.

Julius Clinical is moving decisively toward decentralized and digitally-enabled trial methodologies, making them a strong partner for any project requiring remote patient monitoring, wearable data integration, or hybrid trial designs.

How they like to work

Julius Clinical operates exclusively as a consortium partner — they have never coordinated an H2020 project, which is consistent with their role as a service-oriented CRO that provides trial management expertise to investigator-led research. With 70 unique partners across 17 countries, they work in large, diverse consortia typical of major clinical research initiatives. Their broad network suggests they are a trusted methodological partner that different research groups bring in for trial execution capability.

With 70 unique consortium partners across 17 countries, Julius Clinical has a broad European network spanning academic medical centers, hospitals, patient organizations, and technology companies involved in clinical research. Their geographic spread across 17 countries reflects the multi-national nature of the large clinical trials they support.

What sets them apart

Julius Clinical combines deep clinical trial methodology with a forward-looking investment in decentralized trial infrastructure — a combination that few CROs can demonstrate with EU-funded project evidence. Their Trials@Home involvement (EUR 6.5M) positions them as a go-to partner for anyone designing trials that need to work outside traditional hospital settings. For consortium builders, they offer a rare package: the operational backbone of a professional CRO with demonstrated experience in both conventional and remote trial formats.

Highlights from their portfolio

• Trials@Home
  Their largest project (EUR 6.5M) and a flagship Center of Excellence for remote decentralised clinical trials — a field-defining initiative for the future of clinical research.
• COVID-RED
  Rapid-response project applying wearables and mobile health for early COVID-19 detection, demonstrating ability to deploy remote monitoring at speed during a health crisis.
• CONVINCE
  Major multi-center randomized controlled trial comparing renal therapies, showcasing their core competency in running large outcomes-based clinical studies.